Interstitial Lung Disease in Early Rheumatoid Arthritis

Status unconfirmed

Conditions studied: Rheumatoid Arthritis, Interstitial Lung Disease

In brief

The purpose of this study is to determine how interstitial lung disease can be predicted over time in early rheumatoid arthritis. The investigators will study blood and phlegm samples from participants, along with quality of life questionnaires to determine if and how the presence of ILD may impact the participants quality of life over time.

Key facts

Study ID

NCT03977415

Run by

National Jewish Health

People needed

76

Starts

2018-03-27

Expected to finish

2021-08-01

Last updated by the study team

2019-06-06

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 - 90 years
• Diagnosis of "early RA" with or without ILD as defined by ACR/EULAR 2010 criteria and confirmed by a member of the ILD or Rheumatology programs at National Jewish Health (NJH)
• Able to read, speak, and understand English
• Able and willing to perform all study related tasks, including returning to NJH every 6 months for an 18 month period of time

You may not qualify if…

• Subjects who do not meet all inclusion criteria
• Pregnant women

Where it is running

• National Jewish Health — Denver, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.